Literature DB >> 9213198

Effect of poloxamer 407 on the activity of microsomal 3-hydroxy-3-methylglutaryl CoA reductase in rats.

T P Johnston1, W K Palmer.   

Abstract

A single 300-mg i.p. injection of poloxamer 407 (P-407, also called Pluronic F-127) in rats produces a marked hypercholesterolemia for a minimum of 96 h. The purpose of this investigation was to determine mechanisms by which P-407 causes hypercholesterolemia. The enzyme targeted for investigation is the rate-limiting enzyme in cholesterolgenesis, 3-hydroxy-3-methylglutaryl coenzyme A (HMG-CoA) reductase. Injection of P-407 in fasted rats resulted in a significant (p < 0.05) elevation in plasma cholesterol (61.2 +/- 4.2 mg/dl) as soon as 1 h after injection compared with sham-injected controls (50.1 +/- 3.7 mg/dl). Plasma cholesterol (CHO) 24 h after injection of P-407 was 449 +/- 57 mg/dl, with the fastest rate of accumulation occurring from 1 to 12 h (approximately 16.6 mg/dl/h). Over the concentration range of 0-5 mM, P-407 did not appear significantly to affect the activity of HMG-CoA reductase in vitro. However, the enzymatic activity assayed in microsomal fractions isolated from the livers of P-407-injected rats reached a maximum of 262 +/- 42.6 pmol mevalonate/min/mg approximately 15 h after injection, with a subsequent decline to control activity (94.1 +/- 8.7 pmol/min/mg) at approximately 40 h after injection. At 48 h after injection of P-407, the activity of HMG-CoA reductase significantly (p < 0.05) decreased below control values with a mean activity of 9.4 +/- 1.2 pmol/min/mg. The CHO concentrations in hepatic tissue were significantly (p < 0.01) increased at 2 h (3.26 +/- 0.19 mg/g) and 4 h (3.75 +/- 0.38 mg/g) and significantly (p < .01) reduced at 15 h (1.56 +/- 0.19 mg/g) after injection of P-407 compared with tissue CHO concentrations determined in control animals (2.65 +/- 0.18 mg/g). However, the hepatic CHO content appeared to return to control values by 24 h (mean +/- SEM, 2.61 +/- 0.08 mg/g) after injection. These data suggest that the activity of HMG-CoA reductase is regulated by some indirect mechanism(s) after injection of P-407 in rats.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9213198     DOI: 10.1097/00005344-199705000-00003

Source DB:  PubMed          Journal:  J Cardiovasc Pharmacol        ISSN: 0160-2446            Impact factor:   3.105


  8 in total

Review 1.  A review of poloxamer 407 pharmaceutical and pharmacological characteristics.

Authors:  Gilles Dumortier; Jean Louis Grossiord; Florence Agnely; Jean Claude Chaumeil
Journal:  Pharm Res       Date:  2006-11-11       Impact factor: 4.200

2.  Acute P-407 administration to mice causes hypercholesterolemia by inducing cholesterolgenesis and down-regulating low-density lipoprotein receptor expression.

Authors:  Carlos Leon; Kishor M Wasan; Kristina Sachs-Barrable; Thomas P Johnston
Journal:  Pharm Res       Date:  2006-06-21       Impact factor: 4.200

3.  Antihyperlipidaemic activity of swertiamarin, a secoiridoid glycoside in poloxamer-407-induced hyperlipidaemic rats.

Authors:  Hitesh Vaidya; Mandapati Rajani; Vasudevan Sudarsanam; Harish Padh; Ramesh Goyal
Journal:  J Nat Med       Date:  2009-07-25       Impact factor: 2.343

4.  The induction of atherogenic dyslipidaemia in poloxamer 407-treated mice is not mediated through PPARalpha.

Authors:  Thomas P Johnston; David J Waxman
Journal:  J Pharm Pharmacol       Date:  2008-06       Impact factor: 3.765

5.  Circulating free fatty acids are increased independently of PPARgamma activity after administration of poloxamer 407 to mice.

Authors:  Thomas P Johnston; David J Waxman
Journal:  Can J Physiol Pharmacol       Date:  2008-09       Impact factor: 2.273

6.  Effects of prickly pear dried leaves, artichoke leaves, turmeric and garlic extracts, and their combinations on preventing dyslipidemia in rats.

Authors:  Nidal A Qinna; Basma S Kamona; Tawfiq M Alhussainy; Hashem Taha; Adnan A Badwan; Khalid Z Matalka
Journal:  ISRN Pharmacol       Date:  2012-07-02

7.  Poloxamer 407-induced atherosclerosis in mice appears to be due to lipid derangements and not due to its direct effects on endothelial cells and macrophages.

Authors:  Thomas P Johnston; Yuai Li; Ahmed S Jamal; Daniel J Stechschulte; Kottarappat N Dileepan
Journal:  Mediators Inflamm       Date:  2003-06       Impact factor: 4.711

8.  In vitro evaluation of the inhibitory potential of pharmaceutical excipients on human carboxylesterase 1A and 2.

Authors:  Chengliang Zhang; Yanjiao Xu; Qiaoni Zhong; Xiping Li; Ping Gao; Chengyang Feng; Qian Chu; Yuan Chen; Dong Liu
Journal:  PLoS One       Date:  2014-04-03       Impact factor: 3.240

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.